Endoscopic Retrograde Cholangiopancreatography/ERCP Market worth $2.0 Billion by 2026

CHICAGO, March 16, 2022 /PRNewswire/ — According to new market research report Endoscopic Retrograde Cholangiopancreatography/ERCP Market by Product (Upper GI Endoscopes, Stents, Balloons, Catheters, Baskets), Procedure (Biliary Sphincterotomy and Stenting, Pancreatic Sphincterotomy), End User (Hospitals) – Global Forecast to 2026″, Released by MarketsandMarkets™, the Global Endoscopic Retrograde Cholangiopancreatography Market is Expected to Reach $2.0 billion by 2026 from $1.3 billion in 2021 at a CAGR of 9.6% over the forecast period.

Browse the in-depth table of contents at “Endoscopic Retrograde Cholangiopancreatography/ERCP Market”
149 – Tables
51 – Numbers
237 – Pages

Download the PDF brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=170242954

The growth of this ERCP market is majorly attributed to factors such as increasing incidence of cancer, increasing investment by governments and healthcare organizations to improve endoscopy research, increasing focus on investments hospitals for advanced endoscopic instruments and the growing preference for minimally invasive surgeries. . On the other hand, the high costs of endoscopic retrograde cholangiopancreatography devices, the development of other procedures such as EUS and MRCP, and the shortage of physicians and trained endoscopists are factors that are expected to limit the growth of the Marlet.

By product type segment, endotherapy devices segment accounted for the largest market share during the forecast period.

On the basis of product, the endoscopic retrograde cholangiopancreatography market has been segmented into endoscopes, endotherapy devices, visualization systems, energy devices, and others. Factors attributing the large revenues of the endotherapy devices segment include the increasing preference for minimally invasive surgeries and the rising prevalence of gastrointestinal ailments.

Sphincterotomes accounted for the largest market share in the conventional devices segment during the forecast period.

In the endotherapy devices segment, sphincterotomes accounted for the largest market share during the forecast period. This can be attributed to the increasing incidence of pancreatic duct and bile duct stones and the growth of the geriatric population leading to an increase in biliary disorders.

Request sample pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=170242954

North America is dominating the endoscopic retrograde cholangiopancreatography market over the forecast period.

North America accounted for the largest share of the ERCP market in 2020. Rising prevalence of cancer, high investments by hospitals to purchase new ERCP equipment, and emphasis on research activities to improve endoscopy techniques are driving the main factor.

Key players in the global endoscopic retrograde cholangiopancreatography market are Olympus Corporation (Japan), CONMED Corporation (USA), Fujifilm Holdings Corporation (Japan), HOYA Corporation (Japan), KARL STORZ SE & Co. KG (Germany), Ambu A/S (Denmark), Boston Scientific Corporation (USA), Johnson & Johnson (USA), Medtronic, PLC (Ireland), Cook Medical (USA) and B. Braun Melsungen AG (Germany).

Other players in the endoscopic retrograde cholangiopancreatography market include Hobbs Medical, Inc. (US), STERIS PLC (US), Merit Medical Systems, Inc. (US), TeleMed Systems, Inc. (US United States), Changzhou Health Microport Medical Device Co., LTD. (China), Medi-Globe GmbH (Germany), Taewoong Medical Co., Ltd. (South Korea), Huger Medical Instruments Co., Ltd. (China), IntroMedic Co., Ltd. (Republic of Korea), SonoScape Medical Corporation (China), Shanghai AOHUA Photoelectricity Endoscope Co., Ltd. (China), Ottomed (India), Kimberly-Clark Corporation (USA) and Shaili Endoscopy (India)

Talk to the analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=170242954

Browse adjacent markets: Market research on medical devices Reports and advice

Browse related reports:

Endoscopy Equipment Market by product (endoscope (flexible, rigid, capsule, robot-assisted, disposable), visualization systems, accessories), application (gastrointestinal endoscopy, laparoscopy, bronchoscopy, arthroscopy), end user – global forecast to 2026

Gastrointestinal Stents Market with COVID-19 Impact by Product (Biliary Stents, Duodenal Stents, Colonic Stents, Pancreatic Stents, and Esophageal Stents), Material (Self-Expanding Metal Stents and Plastic Stents), Application, End User – Forecast to 2026

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats that will impact 70%-80% of global business revenue. Currently serving 7,500 customers worldwide, including 80% of global Fortune 1000 companies as customers. Nearly 75,000 senior executives from eight industries around the world approach MarketsandMarkets™ for their revenue decision issues.

Our 850 full-time analysts and MarketsandMarkets™ SMEs track global high-growth markets by following the “Growth Engagement Model – GEM”. The GEM aims for proactive collaboration with customers to identify new opportunities, identify most important customers, write “Attack, Avoid and Defend” strategies, identify additional sources of revenue for the company and its competitors. MarketsandMarkets™ now offers 1,500 MicroQuadrants (positioning top performers among Leaders, Emerging Companies, Innovators, Strategic Players) each year in high-growth emerging segments. MarketsandMarkets™ is determined to benefit over 10,000 companies this year for their revenue planning and help them bring their innovations/disruptions to market by providing research ahead of the curve.

MarketsandMarkets’ flagship competitive intelligence and market research platform, “Knowledge Store”, connects over 200,000 markets and entire value chains for a deeper understanding of unmet information, as well as market sizing and niche market forecasts.

Sir. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Office 430
Northbrook, IL 60062
United States: +1-888-600-6441
E-mail: [email protected]
Research overview: https://www.marketsandmarkets.com/ResearchInsight/endoscopic-retrograde-cholangiopancreatography-ercp-market.asp
Visit our website: https://www.marketsandmarkets.com
Source of content: https://www.marketsandmarkets.com/PressReleases/endoscopic-retrograde-cholangiopancreatography-ercp.asp

SOURCE Markets and Markets

Comments are closed.